Armistice Capital, LLC 13D and 13G filings for TETRAPHASE PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-30 8:02 pm Sale |
2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
Armistice Capital, LLC | 0 0.000% |
-1,460,019 (Position Closed) |
Filing |
| 2020-06-30 4:37 pm Unchanged |
2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
Armistice Capital, LLC | 1,460,019 19.990% |
0 (Unchanged) |
Filing |
| 2020-06-11 4:38 pm Purchase |
2020-06-04 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
Armistice Capital, LLC | 1,460,019 19.990% |
40,512 (+2.85%) |
Filing |